伊人色综合久久天天人手人停,日韩爱爱网站,亚洲成人黄色在线播放,亚洲中文字幕日产无码成人片,欧美黄色免费看,亚洲精品国产成人AV,四虎影视国产在线观看精品,久久亚洲Av无码专区
            您好!歡迎訪問上海起發實驗試劑有限公司網站!
            全國服務咨詢熱線:

            15921799099

            當前位置:首頁 > 技術文章 > JCRB細胞庫 JCRB0086

            JCRB細胞庫 JCRB0086

            更新時間:2020-02-14      點擊次數:12909

            JCRB細胞庫,正在收集各種人類和動物培養細胞,包括癌癥和轉基因細胞。細胞資源被分配給日本乃至*的研究人員。這些細胞通過測試微生物污染,病毒污染和交叉培養物污染而獲得全面認證。一些細胞的特征是核型分析和/或細胞表面標記。我們與世界上其他主要的細胞庫合作,正在開發細胞培養和質量控制方法,以支持藥物科學醫學的基礎研究。

             

             

            恭喜上海起發cellbank 細胞報關,順利通關!

            JCRB細胞庫  JCRB0086 [TALL-1]

            接受日期:1986年5月15日
            動物:人的
            性別和年齡:男:28歲
            科學名稱:智人 智人
            病歷:急性淋巴細胞白血病
            分類:
            組織準備:骨髓
            腫瘤起源:骨髓
            開始細胞培養的日期:05/16/86
            細胞的歷史:三宅一生=> NIHS(JCRB)
            介質:含10%胎牛血清的RPMI1640培養基
            通道方法:稀釋。
            CO 2濃度:5%
            單元號 通過時:5x10 ^ 5細胞/ ml
            遺傳學:T細胞
            壽命:無窮
            形態學:淋巴細胞樣
            特點:T細胞淋巴細胞白血病。模式= 95-101
            小區ID數據:可用的
            DNA譜(STR):D5S818:9,12 
            D13S317:8,9 
            D7S820:10,11 
            D16S539:9,10 
            VWA:17,19 
            TH01:7,9 
            Amelogenin:X,Y 
            TPOX:8,11 
            CSF1PO:11,13
            檢測到的病毒DNA:CMV(-),EBV(-),HHV6(-),HHV7(-),BKV(-),JCV(-),ADV(-),parvoB19(-),HBV(-),HTLV1(-), HTLV2(-),HIV1(-),HIV2(-),HPV18(nt)[-/陰性,+ /陽性,nt /未測試]- 說明
            建立者Hiraki,S.
            存入者Miyoshi,I.
            單元庫:NIHS(JCRB)

             

            批號:052386:代幣/種子(JCRB0086)]
             
            • 從庫存中繁殖細胞,傳代號052386 
               P3 * 
              細胞培養的開始日期: 05/30/86 
              安瓿中細胞的濃度: 7.5x10 ^ 5細胞/ ml 
              顯微鏡下的存活率(%): 98%
              使用的抗生素:免費
              支原體,細菌和真菌的檢測結果均為陰性。經測試同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。 







            •  
            •  
            •  
            •  
            •  
            •  

            [這批的文化條件。

            • 培養基: 含10%胎牛血清的RPMI1640培養基。傳代
              方法: 稀釋。
              生長溫度: 37 
              細胞編號: 5x10 ^ 5細胞/ ml 
              備注:在安瓿瓶上批號:052386。
              補充說明: 冷凍前的生存力為99%。在10/20/87檢查生存力。
            批號:071286:分銷(JCRB0086)]
             
            • 傳代號, P6 * 
              細胞培養的開始日期: 86/07/12 
              細胞濃度: 9x10 ^ 5細胞/ ml 
              使用的抗生素:免費支原體,細菌和真菌的檢測均為陰性。經測試同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。
               






            •  
            •  
            •  
            •  
            •  

            [這批的文化條件。

            • 培養基: RPMI1640 + FCS 10%
              通過方法: 稀釋。
              生長溫度: 37 
              細胞傳代數: 5x10 ^ 5細胞/毫升
              其他說明: 確保安培數足夠多。






            •  
            •  
            •  
            •  
            •  

            [附加數據]

             

              下載日期: 2008-06-13)

               

              [批號:111787:分銷(JCRB0086)]
               
              • 通道號, P5 * 
                細胞培養的開始日期: 11/17/87 
                安瓿中細胞的濃度: 2.8x10 ^ 6細胞/ ml 
                使用的抗生素:免費支原體,細菌和真菌的檢測均為陰性。經測試的同工酶,G6PD,LD,NP。
                 






              •  
              •  
              •  
              •  
              •  

              [這批的文化條件。

              • 培養基: RPMI1640 + FCS 10%
                通過方法: 稀釋。
                生長溫度: 37 
                細胞數: 5x10 ^ 5細胞/ ml 
                附加說明: 冷凍前活力為84%。






              •  
              •  
              •  
              •  
              •  

              [附加數據]

               

                下載日期: 2008-06-13)

                 

                [批號:062994:分銷(JCRB0086)]
                 
                • 傳代號, P6 * 
                  開始細胞培養,無需克隆之前的庫存。
                  開始細胞培養的日期: 94/08/94 
                  安瓿中細胞的濃度: 1.02x10 ^ 7細胞/ ml 
                  生長速率: 36.2小時
                  顯微鏡下生存力(%): 79.6 
                  使用的抗生素:免費
                  支原體,細菌和真菌的檢測負。經測試的同工酶,G6PD(typeB),LDH,NP。錨固依賴性:小區標識:可用 
                   







                •  
                •  
                •  
                •  
                •  

                [這批的文化條件。

                • 培養基: 含有10%熱滅活胎牛血清的RPMI1640培養基(JR Scientific,CO19407)。傳代
                  方法: 簡單稀釋法。
                  生長溫度: 37 C傳代
                  細胞數: 1.3x10 ^ 5細胞/ ml






                •  
                •  
                •  
                •  
                •  

                [附加數據]

                 

                STR-PCR(1),
                •  STR-PCR(2),

                下載日期: 2008-06-13)



                cellroot.dbfcellspec.dbf導出。

                參考文獻

                1. 肯塔基州小川市,柴田市,田野清洲,伊野口市,Y。岸田,石本市和安達市。人類免疫缺陷病毒vpr開放閱讀框的變異分析, J。Virol。,63:4110-4114,1989。

                 

                • 注意:通過重組DNA技術將突變引入人免疫缺陷病毒1型傳染性分子克隆的vpr開放閱讀框。在幾種人類CD4 +淋巴細胞細胞系中研究了這些變化對從轉染細胞中重新整合的病毒的復制和細胞病理學特性的影響。在所有情況下,突變病毒均具有傳染性和細胞致病性。但是,當使用低投入劑量時,突變體的生長速度明顯快于野生型病毒。vpr突變體的生長動力學不同于vif和vpu突變體。
                  參考編號:710

                   

                2. I. Miyoshi,S. Hiraki,T. Tsubota,T. Kubonishi,I. Matsuda,Y.,Nakayama,T. Kishimoto,H.和Kimura,I. 源自急性淋巴細胞白血病的人B細胞,T細胞和空細胞白血病細胞系,《 自然》,267:843-844,1977。

                 

                • 注意:盡管已經從急性和慢性骨髓性白血病和急性淋巴細胞性白血病(ALL)的患者中獲得了幾種白血病細胞系,但人類白血病細胞的連續培養仍然是一項艱巨的任務。我們在這里描述了從三名ALL患者中新建立的B細胞,T細胞和空細胞白血病細胞系。
                  參考ID:1878

                   

                3. S. Hiraki,I。Miyoshi,I。Kubonishi,Matsuda,Y。,中山,T.,Kishimoto,H.,Machida,K.,Masuji,H.和Kimura,I。從人淋巴肉瘤建立T細胞系, Gann,69:115-118,1978。

                 

                • 注意:在患有T細胞性limphosarcoma白血病的患者的骨骼狹窄處,通過連續培養建立了稱為TALL-1的白血病T細胞系。TALL-1細胞具有T細胞特性,缺乏Epstein-Barr病毒或其基因組。根據TALL-1細胞的細胞遺傳學,形態學和表面特征,認為它們起源于供體的白血病細胞。
                  參考編號:1879

                 

                NoteName of CellRegistry No.AnimalTissueDescription
                 0-9Page Top   
                 104C1JCRB9036guinea pigfetal bodyfetal carcass, benzo(a)pyrene transformed, diploid
                 16-8JCRB0013mouseantibody-producing hybridomaanti-human erythrocyte, IgM
                 19-7JCRB0014mouseantibody-producing hybridomaanti-human erythrocyte, IgM
                 293JCRB9068humankidneytransformed embryonal kidney by adenovirus (type5)
                 3LLJCRB1348mouselungLewis lung cancer-derived cell line, (C57BL mouse)
                 3'-mRLh-2JCRB0431ratliverhepatoma, (Donryu rat)
                 3'-mRLN-30JCRB0421ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
                 3'-mRLN-31JCRB0422ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
                 3T3 L1JCRB9014mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
                 3T3-L1IFO50416mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
                 3T3-Swiss albinoIFO50417mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
                 3T3-Swiss albinoJCRB9019mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
                 3T6-Swiss albinoJCRB9059mouseembryofibroblast, collagen-secreting, (Swiss albino mouse)
                 3Y1-B Clone 1-6JCRB0734ratembryofibroblast, whole embryo, (Fischer 344 rat)
                 4-2DJCRB0084mouseantibody-producing hybridomaanti-primase complexed with DNA polymerase alpha
                 4-8HJCRB0083mouseantibody-producing hybridomaanti-DNA polymerase alpha, IgG1
                 4G12 hybridomaIFO50090mouse x humanantibody-producing hybridoma4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
                 5RP7IFO50277ratembryofibroblast transformed by c-Ha-ras oncogene
                 6-23 clone 6IFO50270ratthyroidmedullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
                 77N1IFO50280ratkidneytransformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
                 7D4JCRB9092mouse x ratantibody-producing hybridomaanti-murine IL-2 receptors (rat antibody)
                 8305CJCRB0824humanthyroidthyroid anaplastic carcinoma, undifferentiated
                 8505CJCRB0826humanthyroidthyroid carcinoma, undifferentiated
                 9-15cJCRB1181mousebone marrowmesenchymal cell line
                 APage Top   
                 A1IFO50519mouseneuralderives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
                 A-172JCRB0228humanneuralglioblastoma
                 A2058IFO50276humanmelanomamalignant melanoma, metastasis to lymph node
                 A2B5 clone 105IFO50284mouseantibody-producing hybridomaA2B5 antibody, recognizing a glycolipid expressed in neural tissue
                 A3/KAWJCRB0101humanhemo-lymphocyticlymphoma, malignant
                 A31-1-1JCRB1356mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
                 A31-714 C4IFO50021mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
                 A4/FukJCRB0097humanhemo-lymphocyticlymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
                 A-431IFO50411humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF receptor
                 A-431JCRB0004humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
                 A-431JCRB9009humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
                 A549IFO50153humanlung (cancer)adenocarcinoma
                 A549JCRB0076humanlung (cancer)adenocarcinoma
                 A9JCRB0211mouseskinskin fibroblast, 8-azaguanine-resistant, (C3H mouse)
                 A9(0439)-1JCRB0732human chromosome-introducedhuman chromosomal hybridcontains human chromosome Xpter>Xq26::3p12>3pter
                 A9(2621)-4JCRB0730human chromosome-introducedhuman chromosomal hybridcontains human chromosome 12pter>12q24::Xq22>Xqter
                 A9(3552)-2JCRB0731human chromosome-introducedhuman chromosomal hybridcontains human chromosome 11pter>11q23::Xq26>Xqter
                 A9(3884)-1JCRB0729human chromosome-introducedhuman chromosomal hybridcontains human chromosome 16pter>16q24::Xq26>Xqter
                 A9(7151)-3JCRB0728human chromosome-introducedhuman chromosomal hybridcontains human chromosome 17pter>17q11::Xq11>Xqter
                 A9(An4)-2JCRB0727human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 1
                 A9(Bsr10)JCRB2210human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #10
                 A9(BsrX)JCRB2223human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome X
                *8)A9(Hygro13)JCRB2213human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #13
                *8)A9(Hygro14)JCRB2214human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #14
                *8)A9(Hygro21)JCRB2221human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #21
                *8)A9(Hygro22)JCRB2222human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #22
                 A9(Neo1)JCRB2201human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 1
                 A9(neo11)JCRB2211human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #11
                 A9(Neo12)JCRB2212human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #12
                 A9(Neo15)JCRB2215human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #15
                 A9(Neo16)JCRB2216human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #16
                *8)A9(Neo17)JCRB2217human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #17
                 A9(Neo18)JCRB2218human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #18
                 A9(Neo19)JCRB2219human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #19
                 A9(Neo2)JCRB2202human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 2
                 A9(Neo20)JCRB2220human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #20
                 A9(Neo3)JCRB2203human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 3
                 A9(Neo4)JCRB2204human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 4
                 A9(Neo5)JCRB2205human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 5
                 A9(Neo6)JCRB2206human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 6
                 A9(Neo7)JCRB2207human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 7
                 A9(Neo8)JCRB2208human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 8
                 A9(NTI8)-2JCRB0726human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 7
                 ABC-1JCRB0815humanlung (cancer)adenocarcinoma
                 Ac2FJCRB0408ratlivernormal liver, diploid, (Donryu rat)
                 Ac2F(DT)JCRB0416ratliverAc2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
                 Ac2F(ST)JCRB0417ratliverAc2F-derived, spontaneously transformed, (Donryu rat)
                 Ad12-3Y1-Z19JCRB0737ratembryo3Y1 derivative, Ad12-transformed, (Fischer rat)
                 AH601(JTC27)JCRB0132.1ratlivertransplantable ascites hepatoma, (Donryu rat)
                 AH601.P3(JTC27)JCRB0132.2ratlivertransplantable ascites hepatoma, serum-free, (Donryu rat)
                 AH601.P3(JTC27)JCRB0132.3ratlivertransplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
                 AH66tcJCRB0411ratliverascites hepatoma, (Donryu rat)
                 AH70BtcJCRB0412ratliverascites hepatoma, (Donryu rat)
                 AH-7974.P3JCRB0714.1ratliverascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
                 AIGJCRB1105hamster, Chineselunganchorage-independent mutant of CHL
                 Alexander cellsIFO50069humanliver, gallbladderhepatoma, HBs antigen-positive
                 AM-38IFO50492humanneuralglioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
                 AP-16IFO50424mouseneuralastrocyte-progenitor cell line, (C3H/He mouse)
                 AR-EcoScreenJCRB1328hamster, Chineseovaryandrogen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
                 ARLJ301-3JCRB0248ratliverliver epithelial cell, (F344/DuCrj rat)
                 ASF-4-1IFO50418humanskinskin, normal diploid fibroblast
                 ASF-4-2IFO50419humanskinskin, normal diploid fibroblast
                 ASH-3JCRB1073humanthyroidthyroid anaplastic carcinoma
                *2)AT(L)5KYJCRB0331humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
                *2)AT(L)6KYJCRB0332humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
                *2)AT(L)7KYJCRB0333humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
                *2)AT1OSJCRB0308humanskinataxia telangiectasia, fibroblast
                *2)AT2KYJCRB0316humanskinataxia telangiectasia, fibroblast
                 AtT-20JCRB9098mousepituitarypituitary tumor, ACTH producing, (LAF1 mouse)
                 AZ-521JCRB0061humanstomachoriginally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
                 BPage Top   
                 B-1JCRB0243mousetestisLeydig cell tumor, estrogen-dependent, (BALB/c mouse)
                 B104JCRB0117humanhemo-lymphocyticlymphoma, malignant B lymphoma
                *1)B104-R3JCRB0117.1humanhemo-lymphocyticlymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
                 B16 melanomaJCRB0202mousemelanomamelanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
                 B2-17IFO50361humanneuralastrocytoma, thymidine kinase-deficient mutant of U251 MG cells
                 B8/3JCRB0238mousehemo-lymphocyticerythroleukemia
                 B82JCRB0212mouseskinskin fibroblast, bromodeoxyuridine-resistant
                 B95-8JCRB9123cotten-top tamarinhemo-lymphocyticEBV transformed, release EBV infectious to primates
                 BALB/3T3 A31-1-1JCRB0601mouseembryofibroblast, contact inhibited, (BALB/c mouse)
                 BALB/3T3 clone A31JCRB9005mouseembryofibroblast, contact inhibited, (BALB/c mouse)
                 Balb/3T3-A31-1-1IFO50070mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
                 Balb/c 3T3 A31-1-13IFO50299mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
                 Balb/c 3T3 A31-I-1IFO50298mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
                 BALB-MCJCRB0233.0mousemammarymammary cancer, (BALB/cHe mouse)
                 BALB-MC.D3JCRB0233.1mousemammarymammary cancer, (BALB/cHe mouse)
                 BALB-MC.E12JCRB0233.2mousemammarymammary cancer, (BALB/cHe mouse)
                 BALL-1JCRB0071humanhemo-lymphocyticleukemia, acute lymphoblastoid
                 BCE C/D-1bJCRB9129bovinecorneanormal corneal epithelial cell, production of extracellular matrix proteins
                 BCL1 Clone CW13.20JCRB9117mousehemo-lymphocyticleukemia, B cell, (BALB/c mouse)
                *2)BCNS1KOJCRB0324humanskinbasal cell nevus syndrome, fibroblasts
                 BeckerIFO50289humanneuralastrocytoma, GFAP-negative
                 BeWoJCRB9111humanplacentachorio carcinoma, trophoblastic cell line
                 Bhas 42JCRB0149mouseembryoH-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
                 BHK-21(C-13)JCRB9020hamster, Syriankidneykidney, subclone of BHK-21
                 BOKUIFO50323humanuterine cervixcervical squamous cell carcinoma
                 BRL-3AJCRB0025ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
                 BRL-3AJCRB9114ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
                *2)BS2CHJCRB0317humanskinBloom's syndrome, fibroblast
                 BS2CHTERTJCRB1061humanskinBloom's syndrome, fibroblast, immortalized by hTERT
                 BS-C-1IFO50413monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
                *1)BS-C-1JCRB9011monkey, African greenkidneykidney
                 BS-C-1JCRB9126monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
                 BSL2KAJCRB1042humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
                 BW5147.G.1.4.OUA-R.1JCRB9002mousehemo-lymphocyticlymphoma, T cell lymphoma, (AKR/J mouse)
                 CPage Top   
                 C32TGJCRB0227humanmelanomaskin amelanotic melanoma, 6-thioguanine-resistant
                *1)C3H/10T1/2 clone 8JCRB0602mouseembryofibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
                 C3H/10T1/2 clone 8JCRB9080mouseembryofibroblast, contact inhibited, (C3H mouse)
                 C3H/10T1/2-clone 8JCRB0003mouseembryofibroblast, contact inhibited, (C3H mouse)
                 C3H/10T1/2-clone8IFO50415mouseembryofibroblast, contact inhibited, (C3H mouse)
                 C3H/MCA clone 15IFO50042mouseembryo3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
                 C6IFO50110ratneuralglial tumor, GFAP-positive
                 C6JCRB9096ratneuralglial tumor, GFAP-positive
                 C6/36IFO50010mosquitohatched larvaeuseful for replication of flavivirus
                 C6-SF2IFO50425ratneuralC6 subline adapted to serum-free medium
                 Ca SkiIFO50007humanuterine cervixcervical epidermoid cancer
                 Ca9-22JCRB0625humanoralsquamous carcinoma, gingiva
                 Caki-1JCRB0801humankidneyrenal clear cell carcinoma
                 CaR-1JCRB0207humanrectumadenocarcinoma
                *1)CCD 841 CoNIFO50482humancolonestablished from normal colonic tissue, epithelial-like, (distribution finished)
                 CCD-14BrJCRB9101humanlungbronchus, diploid
                 CCD-33CoIFO50483humancolonestablished from normal colon, fibroblast, (the lot in cellbank does not grow)
                 CCK-81JCRB0208humancolonadenocarcinoma
                 CCRF S-180 IIJCRB9089mousesarcomaS-180 sarcoma derivative
                 CCRF-CEMIFO50412humanhemo-lymphocyticleukemia, acute T lymphoblastic
                 CCRF-CEMJCRB0033humanhemo-lymphocyticleukemia, acute T lymphoblastic
                 CCRF-CEMJCRB9023humanhemo-lymphocyticleukemia, acute T lymphoblastic
                 CCRF-HSB2JCRB0031humanhemo-lymphocyticleukemia, acute T lymphoblastic
                 CCRF-SBIFO50026humanhemo-lymphocyticleukemia, acute B lymphoblastic
                 CCRF-SBJCRB0032humanhemo-lymphocyticleukemia, acute B lymphoblastic
                 Ch 1 EsJCRB9037goatesophagusesophagus
                 Chang LiverIFO50016humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
                 Chang LiverJCRB9066humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
                 CHL/IUJCRB0030hamster, Chineselungnormal
                *8)CHO(His9)JCRB2209human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 9
                 CHO(pMAM-HSluc)JCRB0136.2hamster, ChineseovarypMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
                 CHO(pMAM-luc)JCRB0136.1hamster, ChineseovarypMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
                 CHO/HGPRTJCRB0218hamster, ChineseovaryHPRT-deficient CHO cell line
                 CHO-K1IFO50414hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
                 CHO-K1JCRB9018hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
                 CKT-1IFO50003bovinekidneyuseful to assay bovine adenovirus 3
                 CKT-1JCRB0008bovinekidneyuseful to assay bovine adenovirus 3
                 CMK-11-5IFO50430humanhemo-lymphocyticleukemia, acute megakaryoblastic
                 CMK-86IFO50428humanhemo-lymphocyticleukemia, acute megakaryoblastic
                 CoCM-1JCRB0257humancolonadenocarcinoma
                 COLO201JCRB0226humancolonadenocarcinoma
                 COLO320 DMJCRB0225humancolonadenocarcinoma
                 COS-1JCRB9082monkey, African greenkidneySV40 transformed African green monkey kidney
                 COS-7IFO50068monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
                 COS-7JCRB9127monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
                *1)CPAIFO50272bovinevascular systempulmonary artery normal endothelial cell
                 CPAJCRB9025bovinevascular systempulmonary artery normal endothelial cell
                 CPAEJCRB9022bovinevascular systempulmonary artery normal endothelial cell
                 CPT-K5JCRB1067humanhemo-lymphocyticleukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
                 CRFKJCRB9035catkidneykidney, BVD antigen negative
                 cs-17-25JCRB1102hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
                 cs-19-36JCRB1103hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
                 cs-20-5JCRB1104hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
                *2)CS2AWJCRB0310humanskinCockayne's syndrome, fibroblast
                 CS2AWTERTJCRB1059humanskinCockayne's syndrome, fibroblast, immortalized by hTERT
                *2)CS2OSJCRB0309humanskinCockayne's syndrome, fibroblast
                 CS2OS(SVT)JCRB1056humanskinCockayne's syndrome, fibroblast, immortalized by SV40 large T
                 CV-1JCRB9049monkey, African greenkidneykidney, highly susceptible to SV40 infection
                 c-WRT-7-LRJCRB0168rathemo-lymphocyticRLV infected myelomonocytic leukemia.
                 DPage Top   
                *1)D422TJCRB9112humansarcomabenign abdominal desmoid tumor
                 DaudiJCRB9071humanhemo-lymphocyticlymphoma, Burkitt's
                 DBC1.2IFO50484mouseolfactory epitheliumdark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
                 DD-762JCRB1077mousemammarymammary tumor, producing MuMTV, (DD/Tbr mouse)
                 De GinJCRB9078humanskinosteoporosis, skin
                 delta-47JCRB1344humanhemo-lymphocyticmyeloma, secreting IgD
                *1)DempseyJCRB9088humanskinKlinefelter's syndrome, skin
                 Detroit 510JCRB9104humanskingalactosemia, skin
                 Detroit 525JCRB9102humanskinTurner's syndrome, skin
                *1)Detroit 529JCRB9043humanskinDown's syndrome, skin
                 Detroit 532JCRB9044humanskinDown's syndrome, foreskin
                 Detroit 539JCRB9045humanskinDown's syndrome, skin
                 DIG104.10H.1JCRB1213.3mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG1(k)
                 DIG222.4D.5JCRB1213.2mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG2b(k)
                 DL-40JCRB1337humanhemo-lymphocyticlymphoma, non-Hodikin's, Ki-1-positive
                 DLD-1JCRB9094humancolonadenocarcinoma
                 dRLa-74 Clone 2JCRB0409ratliverliver adenoma, (Donryu rat)
                 dRLh-84JCRB0410ratliverhepatoma, (Donryu rat)
                 dRLN-4JCRB0418ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
                 dRLN-6JCRB0420ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
                 dRLN-9JCRB0419ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
                 DSPT200JCRB0217hamster, Syrianembryofetus fibroblast transformed cell
                 DT40JCRB9130chickenhemo-lymphocyticavian leukosis virus (ALV)-induced lymphomas
                 EPage Top   
                 E1A-3Y1-1JCRB0738ratembryo3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
                *1)EB-3IFO50028humanhemo-lymphocyticeliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
                 EBC-1JCRB0820humanlung (cancer)squamous cell carcinoma
                 EBTr (NBL-4)JCRB9038bovinelungembryonic trachea
                *5)ECV304JCRB0744humanvascular systemimmortalized normal endothelium, contamination by T-24/EJ1 was suspected.
                 EGV-4TJCRB0229ratlungimmortal cell line from MNNG-transformed tracheal epithelial cells
                 Ehrlich ascitesJCRB9090mouseascitesEhrlich-Lettre ascites carcinoma
                 EHSIFO50268mousesarcomachondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
                 EJ-1JCRB0710humanbladderbladder carcinoma, contamination by T24 cells has been suspected
                 Ex-3LLJCRB1349mouselungLewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
                 FPage Top   
                 F119JCRB1324mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
                 F2408IFO50015ratembryofibroblast-like, (Fischer rat)
                 F2408 EBNA2 cl-14JCRB0143.5ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-16JCRB0143.2ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-18JCRB0143.3ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-23JCRB0143.6ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-24JCRB0143.4ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-28JCRB0143.7ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 EBNA2 cl-9JCRB0143.1ratembryoEBNA2-transfected, (Fischer rat)
                 F2408 pZipNeoJCRB0143.0ratembryopZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
                 F2408-B812IFO50099ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
                 F2408-B993IFO50100ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
                 F2408-No.20IFO50101ratembryothymidine kinase-deficient F2408 cell line, (Fischer rat)
                 F2408-No.3IFO50098ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
                 F2408-No.7IFO50102ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
                 F25JCRB1323mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
                 F56JCRB1189mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
                 F9JCRB0721mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
                 F9-41JCRB0001mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
                *2)FA18JTOJCRB0315humanskinFanconi's anemia, fibroblast
                *2)FA9JTOJCRB0314humanskinFanconi's anemia, fibroblast
                 FA9JTOTERTJCRB1060humanskinFanconi's anemia, fibroblast, immortalized by hTERT
                 FAA-HTC1JCRB0249ratliverhepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
                 FBHEIFO50154bovinevascular systemheart normal endothelial cell, FGF-dependent for survival
                 FF101JCRB1040ratliverhepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
                 FHs 74 IntJCRB9076humanintestinefetal small intestine, normal, (not intestinal epithelial cell)
                *1)FL*JCRB9016humanHeLa-contaminantoriginally established from amnion, HeLa-contaminated
                 FLAM-76JCRB1346humanhemo-lymphocyticmyeloma, IL-6-dependent, growth is very slow
                 Flow2000IFO50089humanlungfetal lung, normal diploid fibroblast
                *1)Flow2000JCRB0067humanlungfetal lung, normal diploid fibroblast (not available)
                 Flow3000JCRB0068humanneuralnormal fibroblast
                 Flow7000IFO50079humanskinskin, normal diploid fibroblast
                 FLS3IFO50377mouseliverliver stromal cell line
                 FLS5IFO50378mouseliverliver stromal cell line
                 FM3AJCRB0701mousemammarymammary carcinoma, spontaneously obtained, (C3H/He mouse)
                 FM3A APRT~JCRB0703mousemammarymammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
                 FM3A HPRT~JCRB0702mousemammarymammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
                 FM3A TK~JCRB0704mousemammarymammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
                *2)FPC15JTOJCRB0319humanskinfamilial polyposis coli, fibroblasts
                *2)FPC5JTOJCRB0318humanskinfamilial polyposis coli, fibroblasts
                 FRSKJCRB0005ratskinepidermal keratinocyte line from fetal skin
                 FS-1IFO50477humanbone marrow stromabone marrow stromal cell from a myelogenous leukemia patient
                 FSthy21JCRB0719mousethymidylate defectivecomplete defective strain of thymidylate synthase, (C3H mouse)
                 FU97JCRB1074humanstomachadenocarcinoma, poorly differentiated, AFP producing
                 GPage Top   
                 G-292 clone A141B1IFO50107humansarcomaosteosarcoma
                 G-361IFO50009humanmelanomamalignant melanoma, skin
                 G-361JCRB9074humanmelanomamalignant melanoma, skin
                 G-401JCRB9065humankidneyWilms' tumor (embryonal carcinosarcoma of kidney)
                 G-402JCRB9070humankidneyrenal leiomyoblastoma
                 GAKIFO50321humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
                 GAKJCRB0180humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
                 GB-1IFO50489humanneuralglioma, GFAP, vimentin and fibronectin-positive
                 GCH-nu-YSJCRB1201humanuterusgestational uterine choriocarcinoma
                 GH1IFO50269ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
                 GH1JCRB9046ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
                 GH3IFO50105ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
                 GH3JCRB9047ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
                 GHBP116JCRB1226mouseantibody-producing hybridomaanti-human growth hormone receptor antibody-producing, subclass IgG1(k)
                 GOTOJCRB0612humanneuralneuroblastoma, adrenal gland
                 GOTO.P3JCRB0612.1humanneuralneuroblastoma, adrenal gland, serum-free
                *2)GP-1JCRB1366guinea pighemo-lymphocyticGuinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
                 GP8JCRB1198mouseskinhuman beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
                 GRSLIFO50111mousehemo-lymphocyticthymic leukemia, (GR/A mouse)
                *2)GS33JTOJCRB0322humanskinGardner's syndrome, fibroblasts, (M)
                *2)GS7OJTOJCRB0323humanskinGardner's syndrome, fibroblasts
                 HPage Top   
                 HARAJCRB1080.0humanlung (cancer)squamous carcinoma, PTHrP producing
                 HARA-BJCRB1080.1humanlung (cancer)squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
                 HCA-1JCRB1153humanuterine cervixendocervical adenocarcinoma endocervical adenocarcinoma cell line.
                *4)HCC-56JCRB1037humancolonadenocarcinoma, moderately differentiated
                 HCS-2JCRB1203humanuterine cervixcervical squamous cell carcinoma
                 HCSC-1JCRB1205humanuterine cervixendocervical small cell carcinoma
                *2)HCT-2JCRB1362hamster, Syrianhemo-lymphocyticHamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
                 HD-70JCRB1335humanhemo-lymphocyticlymphoma, from Hodgkin's
                 HE-1IFO50297humanembryowhole fetus, normal diploid fibroblast
                 HEC-1JCRB0042humanuterusendometrial adenocarcinoma
                 HEC-108JCRB1123humanuterusendometrial adenocarcinoma
                 HEC-116JCRB1124humanuterusendometrial adenocarcinoma
                 HEC-151JCRB1122humanuterusendometrial adenocarcinoma
                *5)HEC-155JCRB1127humanuterusendometrial adenocarcinoma, (distribution was suspended)
                 HEC-1-AJCRB1117humanuterusendometrial adenocarcinoma
                 HEC-1-BJCRB1193humanuterusendometrial adenocarcinoma
                 HEC-251JCRB1141humanuterusendometrial adenocarcinoma
                 HEC-265JCRB1142humanuterusendometrial adenocarcinoma
                 HEC-50BJCRB1145humanuterusendometrial adenocarcinoma
                 HEC-59JCRB1120humanuterusendometrial adenocarcinoma
                 HEC-6JCRB1118humanuterusendometrial adenocarcinoma
                 HEC-88nuJCRB1121humanuterusendometrial adenocarcinoma
                 HELJCRB0062humanhemo-lymphocyticleukemia, erythroid
                 HeLaJCRB9004humanuterine cervixepitheloid carcinoma
                 HeLa 229JCRB9086humanuterine cervixepitheloid carcinoma
                 HeLa AGJCRB0213humanuterine cervixepitheloid carcinoma, 8-azaguanine-resistant
                 HeLa S3IFO50011humanuterine cervixcervical epithelioid carcinoma
                 HeLa S3JCRB9010humanuterine cervixcervical epitheloid carcinoma, adaptable to a suspension culture
                 HeLa S3 (sc)JCRB0713humanuterine cervixHeLa derivative, can grow in suspension culture
                 HeLa TGJCRB0214humanuterine cervixepitheloid carcinoma, 6-thioguanine-resistant
                 HeLa TG CapJCRB0215humanuterine cervixepitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
                 HeLa.P3JCRB0649humanuterine cervixserum free adapted HeLa cell line
                 HeLa.P3JCRB0649.1humanuterine cervixserum free adapted HeLa cell line, deposited by original developer
                 HeLa.P3(S)JCRB0606humanuterine cervixHeLa cell derived, can grow in a serum-free medium
                 HeLa9903JCRB1318humanuterine cervixhERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
                 Hep G2JCRB1054humanliver, gallbladderhepatoma
                 HEPMJCRB9095humanoralembryonic palatal mesenchyme, limited life span
                 HFb16dJCRB1008humanskinnormal fibroblast transfected with HPV16
                 HFL1IFO50074humanlungfetal lung, normal diploid fibroblast
                 HGH1.1.3JCRB1222.01mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH1.11.1JCRB1222.08mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
                 HGH1.15.3JCRB1222.09mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH1.17.2JCRB1222.03mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH1.31.3JCRB1222.12mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH1.32.4JCRB1222.13mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
                 HGH1.35.2JCRB1222.04mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2a(k)
                 HGH1.41.1JCRB1222.10mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
                 HGH1.46.1JCRB1222.11mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
                 HGH1.6.5JCRB1222.02mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH1.8.1JCRB1222.07mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
                 HGH1.9.3JCRB1222.06mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH2.15.4JCRB1222.16mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(lambda)
                 HGH2.4.2JCRB1222.15mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HGH2.6.1JCRB1222.05mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
                 HHJCRB0099bovinevascular systemcarotid artery normal endothelial cell
                 HKA-1JCRB1017humanskingiant keratoacanthoma
                 HL60JCRB0085humanhemo-lymphocyticleukemia, acute promyelotic, differentiation-inducible
                 HL-60IFO50022humanhemo-lymphocyticleukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
                 HL60(S)JCRB0163humanhemo-lymphocyticleukemia, acute promyelotic
                 HL60RGJCRB0006humanhemo-lymphocyticleukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
                 HLCL-1JCRB0041humanhemo-lymphocyticlymphocyte, peripheral
                 HLEJCRB0404humanliver, gallbladderhepatoma, non-differentiated
                 HLFJCRB0405humanliver, gallbladderhepatoma, non-differentiated
                 HM-1JCRB1208hamster, Syrianhemo-lymphocyticmacrophage line
                 HMC-1-8JCRB0166humanmammarybreast cancer, target cell of the T-cell killer clone T(cHMC-1)
                 HMY-1JCRB1018humanmelanomamalignant melanoma, sole, melanin production is poor
                 HO-1-N-1JCRB0831humanoralsquamous carcinoma, buccal mucosa
                 HO-1-u-1JCRB0828humanoralsquamous carcinoma, mouth floor
                 HOSIFO50106humansarcomaosteosarcoma
                 HPSV178-4-3JCRB1314mouseantibody-producing hybridomaHPSV178 antibody, against GPI-anchorless splice variant of prion protein
                 HR-3Y1-2JCRB0743ratembryo3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
                 hs-103-3JCRB1096hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 hs-164-2JCRB1097hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 hs-171-1JCRB1098hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 hs-172-3JCRB1099hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 hs-211JCRB1100hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 HS-22JCRB1215mousebone marrowmesenchymal stem cell line
                 hs-222-3JCRB1101hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
                 Hs68IFO50350humanskinskin, normal diploid fibroblast
                 HSC-1JCRB1015humanskinsquamous carcinoma
                 HSC-2JCRB0622humanoralsquamous carcinoma, mouth
                 HSC-3JCRB0623humanoralsquamous carcinoma, tongue
                 HSC-4JCRB0624humanoralsquamous carcinoma, tongue
                 HSC-5JCRB1016humanskinsquamous carcinoma
                 HSC-FJCRB1164monkey, Cynomolgushemo-lymphocyticHSV-immortalized T-cell line, susceptible to SIV
                 HSGc-C5JCRB1070humanHeLa-contaminantoriginally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
                 HSP-239JCRB1165chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
                 HSP-250JCRB1177chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
                 HSR-5JCRB1211monkey, rhesushemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
                 HS-SultanJCRB9062humanhemo-lymphocyticestablished as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
                 HT100JCRB0221hamster, Syrianlunglung, new born
                 HT-1080IFO50354humansarcomafibrosarcoma, acetabulum
                 HT-1080JCRB9113humansarcomafibrosarcoma, acetabulum
                 HTC/C3JCRB0164humanthyroidthyroid carcinoma
                 HuCCT1JCRB0425humanliver, gallbladderbile duct carcinoma
                *8)huH-1JCRB0199humanliver, gallbladderhepatoma, HBs antigen-positive, HBc(-), HBe(-).
                 HuH28JCRB0426humanliver, gallbladderbile duct carcinoma
                 HUH-6 Clone 5JCRB0401humanliver, gallbladderhepatoblastoma, well differentiated
                 HuH-7JCRB0403humanliver, gallbladderhepatoma, differentiated
                *1)Human Mucosal cellsJCRB9116humancoloncolon
                 HuO-3N1JCRB0413humansarcomaosteosarcoma, ilium
                 HuO9JCRB0427humansarcomaosteosarcoma
                 HuO9N2JCRB0428humansarcomaosteosarcoma
                 HUV-EC-CIFO50271humanvascular systemnormal endothelial cell, umbilical cord
                 IPage Top   
                 I-10JCRB9097mousetestisLeydig cell testicular tumor (BALB/cJ mouse)
                 I51TJCRB1225mouseskindeficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
                 IAR-20JCRB0610ratlivernon-transformed live cell line, (BD-IV rat)
                 IHH-4JCRB1079humanthyroidthyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
                 IM-9IFO50025humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
                 IM-9JCRB0024humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
                 IM95JCRB1075.0humanstomachadenocarcinoma, moderately differentiated
                 IM95mJCRB1075.1humanstomachadenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
                 IMR-32IFO50283humanneuralneuroblastoma
                 IMR-32JCRB9050humanneuralneuroblastoma
                *4)IMR-90JCRB0516humanlungfetal lung, normal diploid fibroblast
                 IMR-90JCRB9054humanlungfetal lung, normal diploid fibroblast
                 IMR-90-40JCRB0519humanlungfetal lung, normal diploid fibroblast, PDL=about 40
                *3)IMR-90-50JCRB0520humanlungfetal lung, normal diploid fibroblast, PDL=about 50
                 Indian MuntjacJCRB9100Indian Muntjakskinused for chromosomal study
                 IT-26R21IFO50078ratthymusT cell differentiation factor producing, (Wistar rat)
                 IT-45R1IFO50076ratthymusT cell differentiation factor producing, (Wistar rat)
                 IT-45R91IFO50077ratthymusthymic fibroblast, (Wistar rat)
                 IT-79MTNC3IFO50248mousethymusthymic nurse cell, (BALB/c mouse)
                 ITO-IIJCRB0613humantestistesticular tumor, (embryonal tumor)
                 JPage Top   
                 J-111IFO50005humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
                 J-111JCRB0073humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
                 J774.1JCRB0018mousehemo-lymphocyticmonocyte-macrophage, IL-1-producing, (BALB/c mouse)
                 J774A.1JCRB9108mousehemo-lymphocyticmonocyte-macrophage, (BALB/c mouse)
                *6)JHH-1JCRB1062humanliver, gallbladderhepatoma
                *6)JHH-2JCRB1028humanliver, gallbladderhepatoma
                *6)JHH-4JCRB0435humanliver, gallbladderhepatoma
                *6)JHH-5JCRB1029humanliver, gallbladderhepatoma
                *6)JHH-6JCRB1030humanliver, gallbladderhepatoma
                *6)JHH-7JCRB1031humanliver, gallbladderhepatoma, HBV-integration
                 JKT-beta-delJCRB0147humanhemo-lymphocyticleukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
                 JTC-11JCRB0424mouseascitesEhrlich ascites
                 JTC-16 P3JCRB0714ratliverascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
                 JTC19JCRB0608ratlunglung, (JAR-1 rat)
                 KPage Top   
                 K562JCRB0019humanhemo-lymphocyticleukemia, chronic myelogenous, differentiation-inducible
                 K562/ADMJCRB1002humanhemo-lymphocyticleukemia, chronic myelogenous, adriamycin resistant derivative of K562
                 KAI3IFO50518humanhemo-lymphocyticEBV-infected NK-like cell line, IL-2 dependent
                 KALS-1IFO50434humanneuralglioma, GFAP, vimentin and CD13-positive
                 Kasumi-1JCRB1003humanhemo-lymphocyticleukemia, acute myeloid
                 Kasumi-3JCRB1004humanhemo-lymphocyticleukemia, acute myeloperoxidase-negative
                 Kasumi-6JCRB1024humanhemo-lymphocyticleukemia, acute myeloid
                 KATOIIIJCRB0611humanstomachsignet ring cell carcinoma
                 KBJCRB9027humanHeLa-contaminantoriginally established from oral epidermoid carcinoma, HeLa-contaminated
                 KCL-22JCRB1317humanhemo-lymphocyticleukemia, chronic myelocytic, Ph1-positive
                 KDJCRB9103humanoralfibroblast, lip
                 KG-1JCRB0065humanhemo-lymphocyticleukemia, acute myeloblastic
                 KG-1JCRB9051humanhemo-lymphocyticleukemia, acute myelogenous
                 KG-1-CJCRB0236humanneuralmixed glioma, GFAP-negative, S-100-positive
                 KHM-10BJCRB0165humanhemo-lymphocyticlymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
                 KHM-1BJCRB0133humanhemo-lymphocyticmyeloma, multiple, with hyperamylasemia.
                 KHM-3SJCRB0138humanlung (cancer)small cell carcinoma, HTLV-1gene integration
                 KHM-5MJCRB0148humanthyroidthyroid carcinoma, undifferentiated, IL-8 producing
                 KHYG-1JCRB0156humanhemo-lymphocyticleukemia, NK cell-like, IL-2 dependent
                 Ki-JKJCRB1065humanhemo-lymphocyticlymphoma, anaplastic giant cell, Ki-1(CD30)-positive
                 KINGS-1IFO50435humanneuralastrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
                 KMBC-2JCRB1148humanbladderurinary bladder carcinoma
                 KMH-2JCRB1066humanthyroidthyroid anaplastic carcinoma
                 KML-1JCRB1347humanhemo-lymphocyticlymphoma, non-Hodgkins
                 KMLS-1JCRB0200humansarcomaliposarcoma
                 KMM-1JCRB1180humanhemo-lymphocyticmyeloma
                 KMPC-3JCRB1150humankidneycell line derived from renal pelvis
                 KMRC-1JCRB1010humankidneyrenal clear cell carcinoma
                 KMRC-2JCRB1011humankidneyrenal clear cell carcinoma
                 KMRC-20JCRB1071humankidneyrenal cancer
                 KMRC-3JCRB1012humankidneyrenal clear cell carcinoma (growth is very slow)
                *4)KMRC-5JCRB1007humankidneyrenal clear cell carcinoma
                 KMRM-M1JCRB1014humankidneyrenal carcinoma
                 KMS-11JCRB1179humanhemo-lymphocyticmyeloma, multiple, IgG kappa-secreting, EBNA(-)
                 KMS-12-BMJCRB0429humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
                 KMS-12-PEJCRB0430humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
                 KMS-20JCRB1196humanhemo-lymphocyticmyeloma
                 KMS-21BMJCRB1185humanhemo-lymphocyticmyeloma
                 KMS-26JCRB1187humanhemo-lymphocyticmyeloma
                 KMS-27JCRB1188humanhemo-lymphocyticmyeloma
                 KMS-28BMJCRB1192humanhemo-lymphocyticmyeloma
                 KMS-28PEJCRB1191humanhemo-lymphocyticmyeloma
                 KMS-34JCRB1195humanhemo-lymphocyticmyeloma
                 KMS-6JCRB0432humanembryofibroblast, normal diploid
                 KMST-6JCRB0433humanembryofibroblast, immortalized by 60Co irradiation, derivative of KMS-6
                *1)KMST-6/TJCRB0434humanembryofibroblast, immortalized after extensive passages, derivative of KMS-6
                 KNS-42IFO50356humanneuralglioma, GFAP-positive, S-100 and NSE-negative
                 KNS-60IFO50357humanneuralglioma, GFAP, S-100 and NSE-negative
                 KNS-62IFO50358humanlung (cancer)bronchial squamous carcinoma, metastasis to brain
                 KNS-81IFO50359humanneuralglioma, GFAP and S-100-positive, NSE-negative
                 KNS-81-FDIFO50444humanneuralglioma, derivative of KNS-81 adapted to serum-free medium
                *1)KNS-89IFO50360humanneuralgliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
                *5)KO51JCRB0122humanhemo-lymphocyticleukemia, acute myeloblastic, contamination of K562 has been suspected.
                 KO52JCRB0123humanhemo-lymphocyticleukemia, acute myeloblastic
                 KONJCRB0194humanoralsquamous carcinoma, mouth, ras P21 expression
                 KOSC-2 cl3-43JCRB0126.1humanoralsquamous carcinoma, stage III, oral floor
                *5)KOSC-3JCRB0127humanoralsquamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
                *5)KP-1NJCRB0177.0humanpancreaspancreatic cancer, adenocarcinoma (distribution is suspended)
                *5)KP-1NLJCRB0177.1humanpancreaspancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
                 KP-2JCRB0181humanpancreaspancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
                 KP-3JCRB0178.0humanpancreaspancreatic cancer, adenosquamous carcinoma
                 KP-3LJCRB0178.1humanpancreaspancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
                 KP-4JCRB0182humanpancreaspacnreatic ductal cell carcinoma, secreting PTHrP
                 KP-N-RT-BM-1IFO50432humanneuralneuroblastoma, from bone marrow, neuronal and Schwannian differentiation
                 KP-N-SI9sIFO50433humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
                 KP-N-YNIFO50431humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
                 KS-1IFO50436humanneuralglioblastoma
                 KT-5IFO50161mouseneuralastrocyte line, GFAP-positive, (C3H/He mouse)
                 KU812IFO50363humanhemo-lymphocyticleukemia, chronic myeloid
                 KU812JCRB0104humanhemo-lymphocyticleukemia, chronic myeloid
                 KU812EJCRB0104.1humanhemo-lymphocyticleukemia, chronic myeloid
                 KU812FJCRB0104.2humanhemo-lymphocyticleukemia, chronic myeloid
                 KUM10JCRB1176mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM3JCRB1134mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM4JCRB1135mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM5JCRB1178mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM6JCRB1202mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM7JCRB1204mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUM9JCRB1139mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KURAMOCHIJCRB0098humanovaryundifferentiated carcinoma, ascites
                 KUSA-A1JCRB1119mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUSA-H1JCRB1129mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KUSA-OJCRB1132mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
                 KY821JCRB0105humanhemo-lymphocyticleukemia, acute myeloid
                 KY821A3JCRB0105.1humanhemo-lymphocyticleukemia, acute myeloid, subclone of KY821
                 KYM-1JCRB0627humansarcomarhabdomyosarcoma, neck
                *6)KYSE110JCRB1064humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE140JCRB1063humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE150JCRB1095humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE170JCRB1082humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE180JCRB1083humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE220JCRB1086humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE270JCRB1087humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE30JCRB0188humanesophagussquamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE50JCRB0189humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                *6)KYSE70JCRB0190humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
                 LPage Top   
                 L alphaJCRB0125mouseskinL cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
                 L cl 1DJCRB0722mouseskinfibroblast, thymidine kinase-deficient, (C3H mouse)
                 L.P3JCRB0648mouseskinserum-free adapted L929 cell line
                 L.P3(S)JCRB0605mouseskinL cell derived, can grow in a serum-free medium, (C3H mouse)
                 L1210JCRB9026mousehemo-lymphocyticleukemia, lymphocytic, (DBA/2 mouse)
                 L-2JCRB9053ratlungadult lung
                 L2CIFO50210guinea pighemo-lymphocyticleukemic cell, maintainable only by transplantation
                 L5178YJCRB0709mousehemo-lymphocyticlymphoma, methylcholanthrene induced, (DBA/2 mouse)
                 L5178Y TK+/-3.7.2cJCRB0709.1mousehemo-lymphocyticL5178Y derivative, thymidine kinase +/- heterozygotic line
                 L5178Y ts2JCRB0723mousehemo-lymphocyticL5178Y derivative, abnormal cell division at non-permissive temperature
                 L5178Y ts39JCRB0724mousehemo-lymphocyticL5178Y derivative, micronucleation at non-permissive temperature
                 L6IFO50364ratmuscular systemskeletal muscle myoblast
                 L6JCRB9081ratmuscular systemskeletal muscle myoblast
                 L6TGJCRB0209ratmuscular systemskeletal muscle myoblast, 6-thioguanine-resistant
                 L6TG CapJCRB0210ratmuscular systemskeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant

                 

                上海起發實驗試劑有限公司
                地址:上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
                郵箱:xs1@78bio.com
                傳真:021-50724961
                關注我們
                歡迎您關注我們的微信公眾號了解更多信息:
                歡迎您關注我們的微信公眾號
                了解更多信息
                主站蜘蛛池模板: 超碰在线公开中文字幕| 黑人玩弄人妻1区二区| 国产黄a三级三级三级看三级| 国产成人精品日本亚洲999| 干老熟女干老穴干老女人| 我国产码在线观看av哈哈哈网站| 淫欲一区二区中文字幕| 精品熟妇av一区二区三区四区 | 日韩卡一卡2卡3卡4卡| 国产18禁黄美女网站一区二区| 日本国产在线一区二区| 国产原创自拍三级在线观看| 国产精品所毛片视频| 日韩av中文字幕有码| 东乌珠穆沁旗| 国产欧美激情一区二区三区| 最新版天堂资源中文官网| av色蜜桃一区二区三区| 999久久久免费精品国产牛牛| AV成人午夜无码一区二区| 亚洲熟妇夜夜一区二区三区| 亚洲成在人网站AV天堂| 成人国产在线观看高清不卡| 久久精品国产91久久性色tv| 波霸影院一区二区| 在线看免费观看日本特黄一级| 日本免费一区二区三区在线观看| 另类专区欧美在线亚洲免费| 国产成人综合在线女婷五月99播放| 美女胸又www又黄的网站| 91久久综合精品国产丝袜长腿| 精品无码AV无码免费专区| 免费a级毛片无码专区| 日本少妇高潮喷水XXXXXXX | 久热爱精品视频在线观看久爱| 北岛玲精品一区二区三区| 国产成人自拍小视频在线| 久久香蕉国产线看观看精品蕉| 日本最新一区二区三区免费看| 成人黄网站免费永久在线观看| 国产真人做爰免费视频|